EGFR and non-small cell lung carcinoma: Besides the most common oncogenic driver mutations, KRAS and TP53, NSCLC is associated with numerous genetic alterations such as EGFR mutations, ALK translocation, VEGFR2 and c-MET amplification, and others [7,8].